Related references
Note: Only part of the references are listed.Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis A Randomized, Placebo-Phase Trial
Chester V. Oddis et al.
ARTHRITIS AND RHEUMATISM (2013)
Pathogenesis, classification and treatment of inflammatory myopathies
Mei Zong et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Therapeutic Approaches in Myositis
Rohit Aggarwal et al.
CURRENT RHEUMATOLOGY REPORTS (2011)
Long-term remission of severe refractory dermatopolymyositis with a weekly-scheme of immunoglobulin followed by rituximab therapy
Silvia Sanchez-Ramon et al.
RHEUMATOLOGY INTERNATIONAL (2010)
Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis
E. H. S. Choy et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
A pilot trial of rituximab in the treatment of patients with dermatomyositis
Lorinda Chung et al.
ARCHIVES OF DERMATOLOGY (2007)
Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment:: Six-month, double-blind, randomized, placebo-controlled trial
Yuen-Li Chung et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies
CV Oddis et al.
ARTHRITIS AND RHEUMATISM (2005)
Share Paper
